Peixoto, C., Botelho, F., Tomada, I., & Tomada, N. (2016). Sexual patterns in Portuguese medical students and its predictive factors. Revista Internacional de Andrologia, 14(2), 53 - 68.

Tomada, N., Tomada, I., Botelho, F., Pacheco-Figueiredo, L., et al. (2013). Endothelial function in patients with metabolic syndrome and erectile dysfunction: A question of Angiopoietin imbalance?. Andrology, 1(4), 541 - 548.

Carvalho, H. N., Campos Costa, I. M., Botelho, F., & Tomada, N. (2013). The influence of different metabolic syndrome definitions in predicting vasculogenic erectile dysfunction: Is there a role for the index of central obesity?. Aging Male, 16(3), 137 - 142.

Pacheco-Figueiredo, L., Neves, E., Coutinho, P., Botelho, F., et al. (2013). Metabolic syndrome and erectile dysfunction: Assessing the clinical and hemodynamic parameters. Síndrome metabólica e disfunção eréctil - avaliação de parâmetros clínicos e hemodinâmicosRevista Internacional de Andrologia.

Antunes-Lopes, T., Pinto, R., Barros, S. C., Botelho, F., et al. (2013). Urinary neurotrophic factors in healthy individuals and patients with overactive bladder. Journal of Urology, 189(1), 359 - 365.

Tomada, N., Tomada, I., Botelho, F., Cruz, F., & Vendeira, P. (2011). Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. Journal of Sexual Medicine, 8(3), 831 - 839.

Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Exploratory study assessing efficacy and complications of TVT-O, TVT-Secur, and Mini-Arc: Results at 12-month follow-up. European Urology, 59(6), 940 - 944.

Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2011). Intraprostatic botulinum toxin type A administration: Evaluation of the effects on sexual function. BJU International, 107(12), 1950 - 1954.

Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Reply from authors re: Elisabetta costantini and massimo lazzeri. Surgery for stress urinary incontinence: So near and yet so far. Eur Urol 2011;59:945-6. European Urology, 59(6), 947.

Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Single-incision sling system as primary treatment of female stress urinary incontinence: Prospective 12 months data from a single institution. BJU International, 108(10), 1616 - 1621.

Botelho, F., Pina, F., Silva, P., Figueiredo, G., et al. (2010). Vascular endothelial growth factor (VEGF) and prostate pathology. International Braz J Urol, 36(4), 430 - 437.

Guimarães, M., Oliveira, R., Pinto, R., Soares, A., et al. (2009). Intermediate-term results, up to 4 years, of a bone-anchored male perineal sling for treating male stress urinary incontinence after prostate surgery. BJU International, 103(4), 500 - 504.

Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2009). Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: Duration of the effect of a single treatment. BMC Urology, 9(1).